secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIxCrypto Holdings, Inc. (AIXC)
CIK:        0001460702
Form:       8-K
Filed at:   2024-09-05T23:59:59+00:00
Accession:  0001493152-24-035102
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Qualigen Therapeutics prices $3.46M public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Offering: 14,724,058 shares at $0.13 each and pre-funded warrants for 11,972,754 shares at $0.129 per warrant.
- Gross proceeds ~$3.46M; closing expected September 6, 2024.
- Net proceeds to accelerate payment of $2M Senior Note from July 2024 and fund operations.
- Also for clinical/preclinical studies, working capital, possible Marizyme expansion, and acquisitions.
- Univest Securities acted as exclusive placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460702/000149315224035102/0001493152-24-035102-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460702/000149315224035102/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-035102

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer